Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion

By Shinoda M.   Matsuo A.   Toide K.  

European Journal of Pharmacology, Vol. 305, Iss. 1, 1996-06 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin

By Pham I.   Gonzalez W.   Doucet J.   Fournie-Zaluski M.-C.   Roques B.P.   Michel J.-B.  

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 267-276

Elsevier

Access to resources Recommend Favorite

Role of Prolyl Endopeptidase in Intracellular Transport and Protein Secretion

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 3, 2011-05 ,pp. : 327-332

Bentham Science Publishers

Access to resources Recommend Favorite

Combined neutral endopeptidase inhibitors

By Cuculi Florim   Erne Paul  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 457-463

Informa Healthcare

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase inhibitors in the prevention of neuronal cell death

By Larner Andrew J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 481-487

Informa Healthcare

Access to resources Recommend Favorite